Immersion Delivers First-Ever Haptic Medical Simulation for New Lung Cancer Diagnostic Procedure

About Immersion ( www.immersion.com)

Founded in 1993, Immersion Corporation is the recognized leader in developing, licensing, and marketing digital touch technology and products. Using Immersion’s advanced touch feedback technology, electronic user interfaces are more compelling, entertaining, and in many applications, safer and more productive. Immersion’s technology has helped manufacturers develop innovative and creative solutions for products such as hundreds of video games and leading video console gaming systems, medical training simulators installed around the world, driver controls for automotive manufacturers, and mobile phones, such as those from LG and Samsung. Immersion’s patent portfolio includes over 700 issued or pending patents in the U.S. and other countries.

Forward-looking Statements

This press release contains “forward-looking statements” that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause the results of Immersion Corporation and its consolidated subsidiaries to differ materially from those expressed or implied by such forward-looking statements.

All statements, other than statements of historical fact, are statements that may be deemed forward-looking statements, including, but not limited to, statements concerning Immersion being at the forefront of innovation in highly sophisticated medical training that helps improve the quality of healthcare all over the world; Immersion helping more and more doctors become skilled at critical new techniques; the EBUS-TBNA simulation model greatly enhancing learning; virtual reality simulation providing a risk-free, cost-saving, and highly effective way to master EBUS procedures; Immersion providing the most cutting-edge methods of training for challenging procedures that help ensure better healthcare outcomes; and statements regarding the benefits of Immersion products. Immersion’s actual results might differ materially from those stated or implied by such forward-looking statements due to risks and uncertainties associated with our business, which include, but are not limited to, delay in or failure to achieve commercial demand for our products, delay in or failure to achieve the acceptance of force feedback as a critical user experience, unanticipated flaws or defects in Immersion’s EBUS-TBNA simulator, or delay in or failure to develop new or enhanced technologies in response to market demands relating to Immersion’s EBUS-TBNA simulator or other Immersion products.

For a more detailed discussion of these factors, and other factors that could cause actual results to vary materially, interested parties should review the risk factors listed in our most current Form 10-Q, which is on file with the U.S. Securities and Exchange Commission. The forward-looking statements in this press release reflect our beliefs and predictions as of the date of this release. We disclaim any obligation to update these forward-looking statements as a result of financial, business, or any other developments occurring after the date of this release.

Immersion, the Immersion logo, TouchSense, AccuTouch, CathLabVR, EndoscopyVR, and LaparoscopyVR are trademarks of Immersion Corporation in the United States and other countries. All other trademarks are the property of their respective owners.

IMMR – ME

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5908384&lang=en



Contact:

A&R Edelman
Allen Bush, +1-650-762-2940 (Media)
Email Contact
or
The Blueshirt Group
Jennifer Jarman, +1-415-217-7722 (Investors)
Email Contact



« Previous Page 1 | 2             



© 2024 Internet Business Systems, Inc.
670 Aberdeen Way, Milpitas, CA 95035
+1 (408) 882-6554 — Contact Us
ShareCG™ is a trademark of Internet Business Systems, Inc.

Report a Bug Report Abuse Make a Suggestion About Privacy Policy Contact Us User Agreement Advertise